New article on the treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial from the Lancet Infectious Diseases
New Open Access article for those clinicians looking for additional evidence to support expanding your scope of practice to place CVADs in The Netherlands Journal of Medicine
Recent publication on Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism from the Cochrane Database of Systematic Reviews
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
#vascularaccess #FOAMva #thrombosis #FOAMed #FOAMcc #FOAMem
New publication on The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial from the American Heart Journal
#vascularaccess #FOAMva #FOAMed #FOAMcc #FOAMus #FOAMrad #FOAMped #FOAMem
New article on review of worldwide CLABSI due to poor guideline adherence from the journal Antimicrobial Resistance & Infection Control
#vascularaccess #FOAMva #FOAMed #FOAMcc #FOAMems #FOAMrad #infectionprevention #CLABSI
New article between parenteral nutrition and CLABSI from the Journal of Parenteral and Enteral Nutrition
The Relationship Between Parenteral Nutrition and Central Line–Associated Bloodstream Infections
#vascularaccess #FOAMva #FOAMed #FOAMcc #FOAM #FOAMped #infectionprevention #CLABSI
Vascular Access - an evidence-based approach 
You must be logged in to post a comment.